Trials / Active Not Recruiting
Active Not RecruitingNCT06549608
A Retrospective Cohort Study of Mavacamten Patient Support Program in Canada
Patient Characteristics and Treatment Duration of Mavacamten Obstructive HCM Patient Support Program in Canada: A Retrospective Cohort Study
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 685 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This real-world study will describe the demographic and clinical characteristics and mavacamten treatment of adult patients with obstructive hypertrophic cardiomyopathy who participated in the Bristol-Myers Squibb (BMS)-sponsored CAMZYOS Patient Support Program in Canada.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mavacamten | As per product label |
Timeline
- Start date
- 2024-04-20
- Primary completion
- 2024-05-06
- Completion
- 2025-04-18
- First posted
- 2024-08-12
- Last updated
- 2025-02-24
Locations
1 site across 1 country: Canada
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06549608. Inclusion in this directory is not an endorsement.